课题基金 / 基金详情

NEUROMUSCLUAR IMMUNOPATHOLOGY IN EAMG-RESISTANT RATS

NEUROMUSCLUAR IMMUNOPATHOLOGY IN EAMG-RESISTANT RATS
EAMG 抗性大鼠的神经肌肉免疫病理学
批准号:
2080696
负责人:
KEITH A KROLICK
金额:
$13.02万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-05-01 至 1997-04-30

项目摘要

项目成果

KEITH A KROLICK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Gravis (EAMG), immunological differences between helper T cells from two inbred rat strains that explain disease susceptibility on the one hand (in Lewis rats) and disease-resistance on the other hand (in Wistar Furth rats). The working hypothesis for these studies is that the T cell compartment in Wistar Furth rats may lack the ability to activate responsiveness by existing B cells that have the potential to produce disease-causing antibodies; this quality may be related to a lack of T cell reactivity toward an epitope(s) contained within the AChR alpha subunit sequence alpha 100-116 that demonstrates immunodominance in Lewis rats. Studies will include an evaluation of effects on antibody-mediated inducible neuromuscular dysfunction by the elimination of this T cell reactivity in Lewis rats by neonatal tolerance induction and peptide blocking strategies. Proposed studies will also evaluate the importance of this deficit in the Wistar Furth T cell specificity repertoire by comparing the frequency of alpha 100-116 responding cells to the frequency observed in the Lewis response; included in this evaluation will be tests for the ability of WF antigen presenting cells to bind and present the alpha 100-116 peptide that may be responsible for the inability of Wistar Furth T cells to drive an anti-AChR antibody response with disease-causing potential.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Nitirc Oxide in Experimental Myasthenia Gravis
Role of Nitirc Oxide in Experimental Myasthenia Gravis
Role of Nitirc Oxide in Experimental Myasthenia Gravis
Role of Nitirc Oxide in Experimental Myasthenia Gravis
海外基金